Key facts
- This page summarizes Robert Hershberg's Form 4 filing for Adaptive Biotechnologies Corp (ADPT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Mar 2026, 19:49.
Robert Hershberg - 04 Mar 2026 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)
- Reporting relationship
- Director
- Issuer ticker
- ADPT
- Reported as of
- 04 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Mar 2026, 19:49:06 UTC
- Prior SEC filing
- 12 Dec 2025
- Next SEC filing
- 08 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Hershberg by Kyle Piskel, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Hershberg filed Form 4 for Adaptive Biotechnologies Corp (ADPT) on 06 Mar 2026.
Change
- Previous filing in this sequence was filed on 12 Dec 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001274139
Primary reporting owner
HERSHBERG ROBERT
- Relationship
- Director
- Address
- C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1165 EASTLAKE AVE E, SEATTLE
- Signature
- /s/ Robert Hershberg by Kyle Piskel, Attorney-in-Fact
- Signature date
- 06 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ADPT
transaction
Common Stock
Award
- Transaction value
- Shares
- +15,625
- Change %
- +33%
- Price
- $0.000000*
- Shares after
- 62,347
- Date
- 04 Mar 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.